| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $88.5M | +24.1% |
| R&D Expense | $12.0M | +25.5% |
| SG&A Expense | $87.5M | +8.8% |
| Operating Income | -$27.9M | +19.2% |
| Interest Expense | $7.7M | -6.6% |
| Income Tax | $0 | — |
| Net Income | -$35.3M | +17.9% |
| EPS (Basic) | -$4.67 | -1315.2% |
| EPS (Diluted) | -$4.67 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.0M | -27.7% |
| Accounts Receivable | $9.0M | +5.0% |
| Current Assets | $32.5M | -17.6% |
| Total Assets | $87.5M | -10.0% |
| Current Liabilities | $17.4M | +21.8% |
| Long-term Debt | $50.0M | +24.9% |
| Total Liabilities | $89.9M | +17.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.3M | +52.2% |
| Capital Expenditures | $259K | -92.0% |
| Investing Cash Flow | -$403K | +88.3% |
| Financing Cash Flow | $16.4M | -68.5% |
| Free Cash Flow | -$23.5M | +54.6% |
| -1315.2% |
| Stockholders' Equity |
| -$2.5M |
| -111.8% |